This Article  • PDF of this Correction  • Original article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • HIV/AIDS  • Quality of Life  • Drug Therapy  • Adverse Effects  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

JAMA. 2008;300(15):1763.

Incorrect Wording: In the Clinical Crossroads article entitled "A 39-Year-Old Man With HIV-Associated Lipodystrophy" published in the September 3, 2008, issue of JAMA (2008;300[9]:1056-1066), an incorrect word changed the meaning of a sentence. On page 1061 under the heading "Thiazolidinediones," the first sentence should have read: "Thiazolidinediones such as rosiglitazone theoretically could affect HIV lipoatrophy as agonists of peroxisome proliferator–activated receptor , which influences the transcription of genes regulating adipogenesis and glucose and lipid metabolism, thus potentially leading to increased glucose transport into muscles and increased adipogenesis.⁹³"

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?